Related Experiment Video
Updated: Jan 2, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
The role of the changing human microbiome in the asthma pandemic
Timothy C Borbet1, Xiaozhou Zhang2, Anne Müller2
1Department of Pathology, New York University School of Medicine, New York, NY.
Abstract:
Asthma and allergy incidence continue to increase globally. We have made significant strides in treating disease, but it is becoming more apparent that we need to advance our knowledge into the origins of asthmatic disease. Much recent work has indicated that microbiome composition influences immune regulation and that multiple health care factors have driven a loss in microbiome diversity in modern human populations. Evidence is growing of microbiota-driven influences on immune development, asthma susceptibility, and asthma pathogenesis. The focus of this review is to highlight the strides the field has made in characterizing the constituents of the human gastrointestinal microbiota, such as Helicobacter pylori, other members of the neonatal intestinal microbiota, and microbial peptides and metabolites that influence host immunity and immune response to allergens. As we delve further into this field of research, the goal will be to find actionable and clinical interventions to identify at-risk populations earlier to prevent disease onset. Manipulation of the host microbial community during infancy might be an especially promising approach.
Insights
The human gut microbiome influences immune development and asthma risk. Understanding these microbial communities may lead to early interventions for preventing asthma and allergies.
Area of Science:
- Immunology
- Microbiology
- Environmental Health
Background:
- Global incidence of asthma and allergies is rising, necessitating a deeper understanding of disease origins.
- Microbiome composition significantly impacts immune regulation, with modern healthcare practices contributing to reduced microbial diversity.
Purpose of the Study:
- To review current knowledge on the human gastrointestinal microbiota's role in immune development, asthma susceptibility, and pathogenesis.
- To highlight key microbial constituents, including Helicobacter pylori, neonatal intestinal microbiota, and microbial metabolites, influencing host immunity.
Main Methods:
- Literature review focusing on studies characterizing gastrointestinal microbiota.
- Analysis of research linking microbial composition to immune responses and allergic conditions.
- Exploration of potential clinical interventions based on microbiome research.
Main Results:
- Growing evidence supports microbiota-driven influences on immune development, asthma susceptibility, and pathogenesis.
- Specific microbes like Helicobacter pylori and neonatal gut bacteria play roles in immune modulation.
- Microbial peptides and metabolites are identified as key factors influencing host immunity and allergic responses.
Conclusions:
- Further research into the gut microbiome is crucial for understanding asthma and allergy origins.
- Identifying at-risk populations earlier through microbiome analysis could enable preventative strategies.
- Targeted manipulation of the infant microbiome presents a promising avenue for asthma prevention.
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

